Cipla Quality Chemical Industries Limited
|Headquarters||Luzira, Kampala, Uganda|
Executive Director & CEO
|Total assets||US$120 million (2012)|
Number of employees
Cipla Quality Chemical Industries Limited (CQCI) is a pharmaceutical manufacturing company in Uganda. According to a 2007 published report, it was the only company in Africa that manufactured triple-combination antiretroviral (ARV) drugs. CQCI also manufactures the antimalarial drug Lumartem, containing artemisinin and lumefantrine, and the hepatitis B generic medicines Texavir and Zentair.
CQCI's pharmaceutical manufacturing plant is located in Luzira, a neighborhood in Nakawa Division in south-eastern Kampala. The plant is approximately 9 kilometres (5.6 mi), by road, south-east of Kampala's central business district. The coordinates of the plant are 0°18'17.0"N, 32°38'22.0"E (Latitude:0.304723; Longitude:32.639436).
In 2004, Quality Chemicals Limited (QCL) convinced Indian drug maker Cipla to go into a joint venture with QCL and the government of Uganda to establish a pharmaceutical plant in Uganda. Ground was broken in 2005 and the factory was commissioned in 2007, with capacity of 6 million pills daily.
In 2009, TLG Capital invested an undisclosed amount of money in the plant. Later, Capitalworks Investment Partners, a private equity firm based in South Africa, also became a shareholder in the plant. In February 2010, the government of Uganda divested from the plant by selling its shares "at cost" to CQCI. The transaction was valued at US$5 million.
In February 2011, the owners of the plant announced an US$40 million expansion to the production line to include increased production of antiretroviral and antimalarial medication. In April 2012, British media reported that CQCI was in the process of expanding its manufacturing capacity fourfold. The plant had received approval of its processes and products from the World Health Organization. The products were expected to be initially marketed in Burundi, the Democratic Republic of the Congo, Kenya, Rwanda, South Sudan, Tanzania, and Uganda.
According to a 2012 published report, a second plant is being planned to be built next to the first plant, which would raise CQCI's manufacturing capacity to 18 million pills daily.
Ownership of pharmaceutical plant
As of July 2015[update], the shareholding in the pharmaceutical plant was as depicted in the table below:
|Rank||Name of Owner||Percentage Ownership|
|1||Meditab Holdings Limited||51.05|
|2||Quality Chemicals Limited||22.05|
|3||Capitalworks Investment Partners||14.40|
The executive chairman of the board of directors of CQCI is Emmanuel Katongole, who was formerly the managing director of QCIL. He replaced Francis Kitaka, the first person in East Africa to train as a biochemist, The managing director of CQCI is Nevin Bradford.
- Wendo, Charles (6 October 2007). "ARVs Production Starts Monday". New Vision. Kampala. Retrieved 23 June 2014.
- Key, Data (2011). "Quality Chemical Industries, Uganda". Pharmaceutical Technology. Retrieved 23 June 2014.
- CiplaQCi (2015). "Timeline & Milestones". Ciplaqcil.co.ug. Retrieved 10 April 2016.
- CiplaQCi (December 2015). "Komboa Newsletter" (PDF). Ciplaqcil.co.ug. p. 4. Retrieved 10 April 2016.
- Globefeed.com (11 June 2016). "Distance between Post Office Building, Kampala Road, Kampala, Central Region, Uganda and Cipla Quality Chemicals Industries Limited, Port Bell Road, Kampala, Central Region, Uganda". Globefeed.com. Retrieved 11 July 2016.
- Google (11 July 2016). "Location of Cipla Quality Chemical Industries Limited Pharmaceutical Factory, Luzira, Nakawa Division, Kampala, Uganda" (Map). Google Maps. Google. Retrieved 11 July 2016.
- Elvis Basudde, and Robert Kasozi (31 October 2007). "Kitaka, The Brain Behind Africa's First ARVs Factory". New Vision. Retrieved 11 July 2016.
- Anderson, Tatum (21 November 2007). "Trip Into The Unknown". Nature.com. Retrieved 11 July 2016.
- Investment International (9 September 2009). "Ugandan Project Attracts Investors". InvestmentInternational.com. Retrieved 23 June 2014.
- CIPLAQCIL. "Investment Partners in Cipla Quality Chemical Industries Limited". Kampala: Cipla Quality Chemical Industries Limited (CIPLAQCIL).
- BBC (9 April 2012). "Making Drugs Into Profit In Uganda". London: BBC News. Retrieved 11 July 2016.
- Baguma, Raymond (18 May 2012). "Quality Chemicals Giving Ugandans Fighting Chance". New Vision. Retrieved 23 June 2014.
- Ainebyoona, Emmanuel (9 April 2016). "Uganda exports 70 tonnes of ARVs". Daily Monitor. Kampala. Retrieved 11 July 2016.
- Musisi, Frederic (22 November 2013). "Indian firm buys more shares in Quality Chemicals Limited". Daily Monitor. Kampala. Retrieved 28 October 2016.
- Press Release (16 July 2014). "Quality Chemical Industries Limited rebrands following Cipla’s increased shareholding" (PDF). Kampala: Cipla Quality Chemical Industries Limited (QCIL). Retrieved 28 October 2016.
- VCCircle.com (11 July 2011). "TLG Capital ups stake in Cipla’s Africa JV". Reuters India. Retrieved 28 October 2016.
- Senyonyi, Taddewo (4 January 2014). "Francis X. Kitaka: The Unsung Hero of Uganda's Health And Agricultural Sectors". Kampala: The CEO Magazine. Retrieved 9 April 2016.
- Monitor Reporter (18 October 2013). "Emmanuel Katongole: The Founder of Quality Chemicals". Daily Monitor. Kampala. Retrieved 17 March 2015.
- CIPLACQIL (30 November 2013). "Board of Directors of CIPLAQCIL". Ciplaqcil.co.ug. Retrieved 17 March 2015.
- QCIL To Manufacture Special ARVs
- Museveni Opens AIDS Drugs Factory
- Cipla buys 51% in Uganda drugs firm - Sunday, 23 August 2015
- Frontier Private Equity Firms Turn Sights On Africa